Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
暂无分享,去创建一个
K. Anderson | H. Seo | D. Chauhan | J. R. Engen | E. Weisberg | Roxana E. Iacob | S. Dhe-Paganon | D. Das | Ilaria Lamberto | S. Buhrlage | Xiaoxi Liu | Wanyi Hu | N. Schauer | T. Mikhailova | J. Engen | K. Anderson | Deepika Das
[1] S. Tsukamoto,et al. Ceylonins G–I: spongian diterpenes from the marine sponge Spongia ceylonensis , 2017, Journal of Natural Medicines.
[2] M. Bogyo,et al. Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights , 2017, The FEBS journal.
[3] W. Gu,et al. Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors. , 2017, Bioorganic & medicinal chemistry letters.
[4] S. Tsukamoto,et al. Ceylonins A-F, Spongian Diterpene Derivatives That Inhibit RANKL-Induced Formation of Multinuclear Osteoclasts, from the Marine Sponge Spongia ceylonensis. , 2017, Journal of natural products.
[5] E. Altmann,et al. Targeted inhibition of the COP9 signalosome for treatment of cancer , 2016, Nature Communications.
[6] A. Califano,et al. HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma , 2016, Nature Medicine.
[7] S. Tsukamoto,et al. Petroquinones: trimeric and dimeric xestoquinone derivatives isolated from the marine sponge Petrosia alfiani , 2016 .
[8] B. Kessler,et al. DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets , 2016, Front. Genet..
[9] Kay Hofmann,et al. MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes , 2016, Molecular cell.
[10] Hua Wang,et al. Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer. , 2016, The Tohoku journal of experimental medicine.
[11] S. Pierrou,et al. The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells , 2016, Scientific Reports.
[12] Y. Shang,et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. , 2016, The Journal of clinical investigation.
[13] I. Dikic,et al. Bacteria-host relationship: ubiquitin ligases as weapons of invasion , 2016, Cell Research.
[14] Y. Kee,et al. Role of Deubiquitinating Enzymes in DNA Repair , 2015, Molecular and Cellular Biology.
[15] S. Linder,et al. Deubiquitinase inhibition as a cancer therapeutic strategy. , 2015, Pharmacology & therapeutics.
[16] Yong Tae Kwon,et al. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.
[17] V. Tsui,et al. Inhibiting the deubiquitinating enzymes (DUBs). , 2015, Journal of medicinal chemistry.
[18] A. Mesecar,et al. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.
[19] A. Jadhav,et al. Discovery of ML323 as a Novel Inhibitor of the USP1/UAF1 Deubiquitinase Complex , 2014 .
[20] Satpal Virdee,et al. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry , 2014, Nature Communications.
[21] B. Kessler. Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218) , 2014, Expert opinion on therapeutic patents.
[22] Nieves Peltzer,et al. Ubiquitin in the immune system , 2013, EMBO reports.
[23] H. Ovaa,et al. Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. , 2013, Immunity.
[24] D. Rigden,et al. Deubiquitylases from genes to organism. , 2013, Physiological reviews.
[25] H. Yokosawa,et al. Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor. , 2013, Bioorganic & medicinal chemistry letters.
[26] Anindya Dutta,et al. Deubiquitination of Tip60 by USP7 Determines the Activity of the p53-Dependent Apoptotic Pathway , 2013, Molecular and Cellular Biology.
[27] A. Bode,et al. USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer , 2013, Clinical Cancer Research.
[28] C. Niu,et al. Expression of HAUSP in gliomas correlates with disease progression and survival of patients , 2013, Oncology reports.
[29] D. Durocher,et al. Regulation of DNA damage responses by ubiquitin and SUMO. , 2013, Molecular cell.
[30] Parantu K. Shah,et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. , 2012, Cancer cell.
[31] 弗雷德里克·科兰德,et al. Selective and reversible inhibitors of ubiquitin specific protease 7 , 2012 .
[32] G. Petsko,et al. The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK). , 2012, Bioorganic & medicinal chemistry letters.
[33] M. Rapé,et al. The Ubiquitin Code , 2012, Annual review of biochemistry.
[34] V. Battaglia,et al. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. , 2012, Chemistry & biology.
[35] Clemens Vonrhein,et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER , 2012, Acta crystallographica. Section D, Biological crystallography.
[36] K. Haglund,et al. The role of ubiquitylation in receptor endocytosis and endosomal sorting , 2012, Journal of Cell Science.
[37] G. Dianov,et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. , 2011, Chemistry & biology.
[38] T. Sixma,et al. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. , 2011, Molecular cell.
[39] E. Kremmer,et al. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1 , 2011, Nucleic acids research.
[40] S. Dent,et al. The role of deubiquitinating enzymes in chromatin regulation , 2011, FEBS letters.
[41] H. Leonhardt,et al. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1 , 2011, Journal of cellular biochemistry.
[42] A. Ma,et al. Ubiquitin makes its mark on immune regulation. , 2010, Immunity.
[43] P. Cohen,et al. Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases? , 2010, Cell.
[44] Yiqing Zhao,et al. DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination , 2010, Science Signaling.
[45] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[46] T. Ludwig,et al. Inactivation of HAUSP in vivo modulates p53 function , 2010, Oncogene.
[47] Graeme Winter,et al. xia2: an expert system for macromolecular crystallography data reduction , 2010 .
[48] Wolfgang Kabsch,et al. Integration, scaling, space-group assignment and post-refinement , 2010, Acta crystallographica. Section D, Biological crystallography.
[49] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[50] W. Gu,et al. Suppression of cancer cell growth by promoting cyclin D1 degradation. , 2009, Molecular cell.
[51] David Komander,et al. Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.
[52] J. Rain,et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells , 2009, Molecular Cancer Therapeutics.
[53] H. Ploegh,et al. Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection , 2009, Cell Host & Microbe.
[54] Daniela Hoeller,et al. Targeting the ubiquitin system in cancer therapy , 2009, Nature.
[55] John R. Engen,et al. Conformational disturbance in Abl kinase upon mutation and deregulation , 2009, Proceedings of the National Academy of Sciences.
[56] Wentao Fu,et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication , 2008, Proceedings of the National Academy of Sciences.
[57] John R Engen,et al. High-speed and high-resolution UPLC separation at zero degrees Celsius. , 2008, Analytical chemistry.
[58] D. Sterner,et al. Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities , 2008, Protein science : a publication of the Protein Society.
[59] Vikki M. Weake,et al. Histone ubiquitination: triggering gene activity. , 2008, Molecular cell.
[60] Claude C. Warzecha,et al. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. , 2008, Molecular cell.
[61] H. Stunnenberg,et al. A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. , 2008, Molecular cell.
[62] T. Hunter. The age of crosstalk: phosphorylation, ubiquitination, and beyond. , 2007, Molecular cell.
[63] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[64] C. Brancolini,et al. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. , 2006, Cancer research.
[65] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[66] S. Srinivasula,et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. , 2006, Nature cell biology.
[67] T. Wales,et al. Hydrogen exchange mass spectrometry for the analysis of protein dynamics. , 2006, Mass spectrometry reviews.
[68] P. Evans,et al. Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.
[69] F. Karch,et al. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. , 2005, Molecular cell.
[70] D. Fushman,et al. Polyubiquitin chains: polymeric protein signals. , 2004, Current opinion in chemical biology.
[71] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[72] B. Vogelstein,et al. HAUSP is Required for p53 Destabilization , 2004, Cell cycle.
[73] Carlo Rago,et al. Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.
[74] Muyang Li,et al. A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.
[75] Víctor Quesada,et al. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. , 2004, Biochemical and biophysical research communications.
[76] Muyang Li,et al. Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.
[77] Richard Pazdur,et al. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. , 2003, The oncologist.
[78] Aaron Ciechanover,et al. The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.
[79] Muyang Li,et al. Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.
[80] Doriano Fabbro,et al. Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412. , 2002, Cancer cell.
[81] J. Qin,et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.
[82] A. Ciechanover,et al. Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[83] Chris Sander,et al. MView: a web-compatible database search or multiple alignment viewer , 1998, Bioinform..
[84] K D Wilkinson,et al. Crystal structure of a deubiquitinating enzyme (human UCH‐L3) at 1.8 å resolution , 1997, The EMBO journal.
[85] R. Everett,et al. A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.
[86] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[87] A Ciechanover,et al. Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[88] A Ciechanover,et al. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.